Skip to main content
. 2020 Jul 27;12:6373–6383. doi: 10.2147/CMAR.S256490

Figure 3.

Figure 3

KLF16 silencing inhibited breast cancer cell proliferation in vitro and in vivo. MCF-7 and MDA-MB-231 cells were transfected with two different KLF16-targeting shRNAs or control shRNA (shSCR). (A) The knockdown efficiency was confirmed with Western blotting. β-Actin was chosen as an internal control in Western blotting. (B) CCK-8 assay was used to assess the viability of each cell group at the indicated time points. (C) Colony formation assay in MCF-7 and MDA-MB-231 cells expressing the indicated shRNAs. (D) The numbers of colonies in each group were counted. Each value represents the mean ± standard deviation of three independent experiments in (B and D); ***p<0.001. (E) The images of xenografts are shown. (F) The final tumor volumes are shown. (G) The tumor weights are shown. Bars in F and G represent mean ± standard deviation (Mann–Whitney, **p <0.01, n=5).